Australia markets close in 1 hour 36 minutes

Medical Developments International Limited (MVP.XA)

Cboe AU - Cboe AU Real-time price. Currency in AUD
Add to watchlist
0.4550-0.0100 (-2.15%)
As of 01:48PM AEST. Market open.
Currency in AUD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.61
52-week change 3-44.97%
S&P500 52-week change 322.38%
52-week high 31.8300
52-week low 30.4150
50-day moving average 30.6582
200-day moving average 30.8424

Share statistics

Avg vol (3-month) 316.77k
Avg vol (10-day) 328.23k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 870.1M
% held by insiders 117.75%
% held by institutions 117.41%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -57.27%
Operating margin (ttm)-77.96%

Management effectiveness

Return on assets (ttm)-13.86%
Return on equity (ttm)-23.42%

Income statement

Revenue (ttm)33.55M
Revenue per share (ttm)0.39
Quarterly revenue growth (yoy)8.70%
Gross profit (ttm)N/A
EBITDA -20.83M
Net income avi to common (ttm)-19.21M
Diluted EPS (ttm)-0.2640
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)15.7M
Total cash per share (mrq)0.18
Total debt (mrq)2.43M
Total debt/equity (mrq)3.20%
Current ratio (mrq)2.78
Book value per share (mrq)0.88

Cash flow statement

Operating cash flow (ttm)-14.74M
Levered free cash flow (ttm)-12.79M